Revolution Medicines

Senior Director, Global Pre-Approval Patient Access

Revolution Medicines$232K — $290K *
US-AnywhereRemote in United States
Pharmaceuticals & Biotech
11 - 15 years of experience
Job Overview by Ladders

Qualifications

  • Bachelor's degree in a healthcare field (advanced degree preferred)
  • 12+ years of clinical trial operations and oncology early access experience
  • Proven track record of designing and executing global early access programs
  • Deep knowledge of global regulatory authorities' programs and timelines
  • Strong organizational skills with a proactive, resourceful approach
  • Experience leading large cross-functional teams with a collaborative mindset
  • Ability to manage complex issues and deliver high-quality solutions.

Responsibilities

  • Develop and implement enterprise-wide strategy for early access programs
  • Design and coordinate free-of-charge named-patient and cohort access initiatives globally
  • Lead cross-functional collaboration among Clinical, Regulatory, and other departments
  • Establish governance for evaluating and prioritizing new early access programs
  • Oversee program operations and manage vendor relationships
  • Create company-wide policies for ethical access decisions
  • Collaborate with Development on early access planning aligned with lifecycle strategies.

Benefits

  • Robust equity awards
  • Strong benefits package
  • Extensive learning and development opportunities
Full Job Description
The Opportunity:

The Senior Director of Global Pre-Approval Patient Access will lead the strategy, design, and execution of global early access programs for Revolution Medicines' pipeline. This role is critical to enabling appropriate patient access to investigational therapies targeting RAS-addicted cancers while ensuring alignment with clinical development/operations, regulatory requirements, and company priorities.

This role will report into the Head of Advocacy and Society Engagement and play an integral role in our commitment to supporting appropriate patient access to medicines.
  • Own and implement the enterprise wide strategy surrounding EA aligned with clinical and regulatory milestones; ensure distinction with other patient access initiatives considered or implemented.
  • Design and implement free of charge named-patient and cohort early access programs globally.
  • Serve as overall cross-functional leader of the programs, liaising across Clinical, Regulatory, Medical Affairs, Commercial, Legal, Supply Chain, as needed.
  • Create and chair governance for global evaluation, and prioritization of potential new programs
  • Manage the functional program operations, including vendors and long-term organizational capabilities
  • Establish company wide policies, SOPs, and frameworks for ethical and compliant access decisions and ensure adherence to global SOPs and regulatory requirements.
  • Partner with Development to ensure early access planning is aligned with Lifecycle strategy.
  • During integrated strategic planning, align closely with Supply Chain, Medical Affairs and Development to ensure supply readiness and feasibility assessments.
  • Partner with global commercial teams around timing and transitions based on regulatory milestones and reimbursement.
  • Lead budget forecasting, and program KPIs.

Required Skills, Experience and Education:
  • The successful candidate will be a highly organized, proactive, resourceful, self-motivated individual with a roll-up-the-sleeves mentality and a strong sense of urgency. They should possess a proven track record of setting, driving, and delivering on objectives and projects, and have demonstrated ability to successfully collaborate with others.
  • Bachelor degree in a healthcare field with advanced degree preferred.
  • Minimum of 12 years of clinical trial operations and Oncology EA experience in a biotech/pharmaceutical company.
  • Demonstrated ability to design and execute global EA programs.
  • Deep understanding of key glabl regulatory authorities' programs and timelines.
  • Excellent organizational savvy with willingness and ability to work independently, think creatively, and shift gears depending on changing priorities and deadlines.
  • Strong relationship management with a keen understanding of different roles inside of a biotech/pharmaceutical company.
  • Significant experience leading large cross-functional teams.
  • Proven ability to take initiative and consistently deliver high-quality solutions.

Preferred Skills:
  • Experience with global product launches including support of launch planning.
  • Strong knowledge of oncology drug development, including challenges associated with precision medicine and biomarker-driven trials.
  • Ability to navigate complex ethical and operational decisions in high unmet need patient populations.
  • Experience interacting with CROs, treating physicians, patient advocacy groups, and health authorities.
  • Understanding of HTA/reimbursement timing impacts on pre-commercial access demand.

#LI-Remote #LI-VN1

The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.

Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.

Base Pay Salary Range

$232,000-$290,000 USD

About Revolution Medicines

Revolution Medicines is a clinical-stage precision oncology company focused on developing targeted therapies to inhibit elusive frontier targets within notorious growth and survival pathways, with particular emphasis on RAS and mTOR signaling pathways. The company's proprietary platform enables the discovery and development of small molecules that bind covalently to proteins. Revolution Medicines was founded in 2014 and is headquartered in South San Francisco, California.
Learn more about Revolution Medicines
Size
201 employees
Market Cap
$2.1 billion
Industry
Net Income
-$108.1 million
Revenue
$42.9 million
NASDAQ

Similar Jobs

More Jobs at Revolution Medicines

More Pharmaceuticals & Biotech Jobs

Find similar Senior Director, Global Pre-Approval Patient Access jobs: